Brandywine Oak Private Wealth’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,375
| Closed | -$294K | – | 299 |
|
|
2022
Q2 | $294K | Buy |
1,375
+523
| +61% | +$112K | 0.04% | 247 |
|
|
2022
Q1 | $241K | Buy |
852
+178
| +26% | +$50.4K | 0.03% | 311 |
|
|
2021
Q4 | $264K | Sell |
674
-89
| -12% | -$34.9K | 0.03% | 286 |
|
|
2021
Q3 | $314K | Sell |
763
-31
| -4% | -$12.8K | 0.04% | 242 |
|
|
2021
Q2 | $293K | Sell |
794
-129
| -14% | -$47.6K | 0.03% | 253 |
|
|
2021
Q1 | $267K | Sell |
923
-44
| -5% | -$12.7K | 0.04% | 231 |
|
|
2020
Q4 | $241K | Sell |
967
-92
| -9% | -$22.9K | 0.04% | 238 |
|
|
2020
Q3 | $239K | Sell |
1,059
-143
| -12% | -$32.3K | 0.04% | 224 |
|
|
2020
Q2 | $209K | Buy |
+1,202
| New | +$209K | 0.04% | 236 |
|
|
2019
Q1 | – | Sell |
-1,095
| Closed | -$125K | – | 295 |
|
|
2018
Q4 | $125K | Buy |
+1,095
| New | +$125K | 0.03% | 253 |
|